![]() The plaintiff’s case-in-chief lasted for five weeks. As a result, he suffered severe pain and needed additional surgery. According to Johns, the mesh’s defective design caused it to adhere to his bowel tissue. Bard’s Ventralight ST hernia mesh implanted to repair an abdominal hernia. In September 2021, the first bellwether trial finally began for a case that the defense selected. The scheduling of these six trials experienced delays and complications due to the COVID-19 pandemic. In 2019, 12 cases were selected as a bellwether discovery pool, which permitted a brief period of discovery review before both the plaintiff and defense side each picked three cases to be scheduled for trial. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation, 18-MD-2846). Bard were consolidated into a multidistrict litigation in the United States District Court of the Southern District of Ohio ( In Re: Davol, Inc./C.R. Hernia Mesh Lawsuits The Multidistrict Litigationįour years ago, the hernia mesh lawsuits against C.R. Furthermore, the lawsuits claim that the mesh material was not fit for permanent implantation inside the body. Bard claim that the mesh material was defectively designed and inadequately tested. Subsequently, this can cause internal infections, bowel obstructions, and severe abdominal pain. This results in the mesh attaching to adjacent tissue and organs. In other cases, the mesh coating would dissolve or not properly function. As a result, patients would experience pain and inflammation. However, patients began experiencing problems with the implant, such as immune system responses triggered by the mesh material. The purpose of the mesh is to strengthen and reinforce the surgically repaired tissue without attaching it to any adjacent tissue. The company makes the mesh from polypropylene. Bard’s devices to permanently remain in the body after implantation. Unlike absorbable implants, the manufacturers designed C.R. ![]() The company is one of the earliest pioneers in permanent mesh implants. ![]() Bard’s hernia mesh products have a long history. Bard in a multidistrict litigation, its April trial loss may set the tone for future trials. With over 16,400 lawsuits still pending against C.R. Bard, one of three medical device manufacturers facing lawsuits for hernia mesh products, recently lost a bellwether trial. But hernia mesh litigation is far from over. The lawsuits reached a settlement for a collective $1.1 billion. Over the years, there have been over 50,000 lawsuits related to hernia mesh products. One study found that nearly one-third of patients experienced adverse side effects including bowel obstruction, perforation of organs and tissues, and the need for corrective surgery. ![]() However, with their popularity also comes a high frequency of complications. Hernia mesh products- medical devices used to repair torn hernias-are big business, with over one million implantations done each year. ![]()
0 Comments
Leave a Reply. |